Lundbeck Expands EVERSANA AI Commercialization | Lucid Diligence Brief
Lundbeck Expands EVERSANA AI Across Its U.S. Commercial Organization…
Gene Therapy: Efficacy, Safety, and Market Sentiment in an AI-Driven Search World
As AI increasingly mediates how patients, clinicians, and investors discover…
Winning in AI Search: 12 Key Takeaways for Brand Owners in the Age of AI Search
AI-driven web search: 12 takeaways for healthcare brand owners Dive…
How LucidQuest Supported a leading pharma in Hemophilia to better position its Hemophilia A assets vs. a key competitor in the US
The Challenge: How can a Top-20 Pharma company uncover the key competitor's…
How a large cap pharma in the Direct Oral Anticoagulant Space (DOAC) space updated its promotional tactics to regain lost SoV.
The challenge: Stimulating conversation around your brand when your competitors…
How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts.
The Challenge: Mapping prostate cancer stage and identifying key stakeholders…
How we helped a CNS mid-size pharma understand a new competitor in the EU after researching its sales force.
The Challenge: Assessing the impact of a new competitive entry in the CNS space…
How a large-cap pharma in the Direct Oral Anticoagulant Space (DOAC) space updated its promotional tactics to regain lost SoV
The Challenge: Stimulating conversation around your brand when your competitors…